Digital Therapeutics – The Human Story Behind the Technology

Medidata’s Chief Strategy Officer, Lisa Moneymaker, moderated a panel to discuss the transformative impact of Digital Therapeutics (DTx) and Software-Enhanced (SE) Drugs^TM on patient care, focusing on the human needs driving the technology, the science making it possible, and the revolutionized patient experience it delivers.

Panelists:

• Dr. Nimita Limaye, Research VP Life Sciences R&D Strategy & Technology, IDC
• Anne Marie Mercurio, Patient Advocate
• Dr. Viveca Livezey, SVP, Clinical Development, Click Therapeutics